The participation of circadian rhythms in the process of apoptosis can be evidenced by the mutation of CRY that can activate p53-independent apoptosis pathways followed by the elimination of pre-malignant and malignant cells to delay tumor progression [87]. The gene discussed is TP53; the disease is neoplasm.